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Abstract
Piperidine nitroxides such as TEMPOL have been widely used as antioxidants in vitro and in vivo. MitoTEMPOL is a
mitochondria-targeted derivative of TEMPOL designed to protect mitochondria from the oxidative damage that they
accumulate, but once there is rapidly reduced to its hydroxylamine, MitoTEMPOL-H. As little is known about the
antioxidant efficacy of hydroxylamines, this study has assessed the antioxidant activity of both MitoTEMPOL and
MitoTEMPOL-H. The hydroxylamine was more effective at preventing lipid-peroxidation than MitoTEMPOL and
decreased oxidative damage to mitochondrial DNA caused by menadione. In contrast to MitoTEMPOL, MitoTEMPOL-H
has no superoxide dismutase activity and its antioxidant actions are likely to be mediated by hydrogen atom donation.
Therefore, even though MitoTEMPOL is rapidly reduced to MitoTEMPOL-H in cells, it remains an effective antioxidant.
Furthermore, as TEMPOL is also reduced to a hydroxylamine in vivo, many of its antioxidant effects may also be mediated
by its hydroxylamine.
Keywords: MitoTEMPOL, nitroxide, hydroxylamine, lipid peroxidation, mtDNA, antioxidant
Abbreviations: AAPH, 2,2?-azobis(2-amidinopropane); BHM, bovine heart mitochondrial membranes; BSA,
bovine serum albumin; MitoTEMPOL, 2,2,6,6-tetramethyl-4-[5-(triphenylphosphonio)pentoxy]piperidin-1-oxy
bromide; MitoTEMPOL-H, hydroxylamine of MitoTEMPOL; MitoQ, [10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1,
4-cyclohexadien-1-yl)decyl]triphenylphosphonium methanesulphonate; MitoQH2, [10-(3,6-dihydroxy-4,5-dimethoxy-2-
methylphenyl)decyl]triphenylphosphonium; MDA, malondialdehyde; mtDNA, mitochondrial DNA; PBS, phosphate-
buffered saline; QPCR, quantitative PCR; ROS, reactive oxygen species; SOD, superoxide dismutase; SUV , small
unilamellar phosphatidylcholine vesicles; TBARS, thiobarbituric acid-reactive species; TEMPOL, 4-hydroxy-2,2,6,6-
tetramethylpiperidine-1-oxy radical; TPP, triphenylphosphonium moiety
Introduction
Piperidine nitroxides such as TEMPOL (4-hydroxy-
2,2,6,6-tetramethylpiperidine-1-oxy radical; Figure
1) exhibit potent antioxidant effects in a variety of
systems [1 9]. These properties have been ascribed
to the ability of these nitroxides to catalyse the
dismutation of superoxide [10,11], to detoxify re-
dox-reactive forms of transition metal ions (ferrous,
cuprous, ferryl) [12 14] and to react directly with
many radicals, forming adducts with varying stabi-
lities and breakdown chemistries [15,16].
As mitochondria produce significant amounts of
reactive oxygen species (ROS) and oxidative damage
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gies [17], we synthesized a mitochondria targeted
TEMPOL derivative called MitoTEMPOL (2,2,6,6-
tetramethyl-4-[5-(triphenylphosphonio)pentoxy]piper-
idin-1-oxy bromide) [18] (Figure 1). MitoTEMPOL
comprises the piperidine nitroxide TEMPOL unit
conjugated with a triphenylphosphonium (TPP) moi-
ety [18]. As expected [19,20], the lipophilic TPP
cation moiety enabled MitoTEMPOL to rapidly
traverse biological membranes, accumulate several-
hundred-fold in energized mitochondria and in-
creased its affinity for adsorption to phospholipid
bilayers [18]. The intention was that this selective
targeting of TEMPOL to mitochondria would render
MitoTEMPOL a more effective antioxidant, as has
been done by targeting other antioxidants to mito-
chondria [20]. Intriguingly, we found that MitoTEM-
POL was rapidly and completely reduced to its
hydroxylamine MitoTEMPOL-H within respiring
mitochondria by ubiquinol in the inner membrane
[18]. Reduction of cyclic nitroxides in biological
systems had been known for several decades [21,22],
but the extent, site of reduction and the identity of the
reductant had remained conjectural. For MitoTEM-
POL this reduction is so extensive that the nitroxide
cannotbedetectedinrespiringmitochondria,suggest-
ing that any antioxidant activity of MitoTEMPOL
within mitochondria would be due to its hydroxyla-
mine, MitoTEMPOL-H [18]. Hydroxylamines, in-
cluding those derived from piperidine nitroxides
[15,23 25] as well as tert-butylhydroxylamine
[26,27], have antioxidant properties, however, the
mechanism of these effects has not been studied in
detail. Therefore here we have determined the anti-
oxidant activity of MitoTEMPOL and MitoTEM-
POL-H in order to assess whether targeting
MitoTEMPOL to mitochondria remains a viable
antioxidant strategy. We found that MitoTEMPOL-
H was effective at preventing lipid peroxidation and at
preventing mitochondrial DNA (mtDNA) damage,
while the antioxidant activity of MitoTEMPOL was
similar to that of TEMPOL. Therefore, targeting
nitroxides to mitochondria is a valid antioxidant
strategy, as the hydroxylamine is a potent antioxidant.
Materials and methods
Chemicals
MitoTEMPOL and MitoQ were prepared as pre-
viously described [18,28]. TEMPOL was from Al-
drich, UK, propylTPP from Sigma, UK C11-
BODIPY was from Molecular Probes, OR, USA. To
reduce MitoTEMPOL to the hydroxylamine, Mito-
TEMPOL-H, MitoTEMPOL (10 mL of a 0.5 M
solution in ethanol) was mixed with 10 mL of 0.5 M
sodium ascorbate (pH 6), reacted for 1 min at
room temperature, during which time the colour
changed from orange to pale yellow [29]. The reaction
mixture was then diluted with 1 mL water and
extracted into 1 mL CH2Cl2. The lower, organic
phase was then removed, evaporated and the white
residue was dissolved in water. The product was 
98% MitoTEMPOL hydroxylamine (MitoTEM-
POL-H), based on
1H-NMR comparison with phe-
nylhydrazine-reduced samples. MitoTEMPOL-H
slowly becomes oxidized in aerated solutions and
therefore aliquots were stored in aqueous solution
under an inert atmosphere at 208C.
Preparation of mitochondria
Rat liver mitochondria were prepared by homogeniza-
tion followed by differential centrifugation in 250 mM
sucrose, 5 mM Tris-HCl, 1 mM EGTA, pH 7.4 [30].
Protein concentration was determined by the biuret
assay using bovine serum albumin (BSA) as a stan-
dard [31]. Bovine heart mitochondrial membranes
were prepared by disruption of bovine heart mito-
chondria in a blender followed by collection of the
membranes by centrifugation [32,33].
Preparation of phospholipid vesicles
Small unilamellar phosphatidylcholine vesicles (SUV)
were prepared as described [34]. Egg yolk phospha-
tidylcholine (5 mg) was dissolved in 100 ml chloro-
form, pipetted to a glass tube and evaporated to
dryness overnightunderastreamofN2.Totheresidue
5m lo f5 0m M Tris-Cl buffer (pH 7) was added and
the lipid was left to hydrate for 1 h on a roller. The
mixture was then vortexed vigorously and placed in a
Decon F5Minor sonicating water bathfor 30min at
room temperature. The SUVs had a mean external
spherical diameter of 86926 nm (n 35,9SD) [34].
Cell culture
C2C12 cells (murine myoblast-like cell line, from
ECACC) were grown in Dulbecco’s modified Eagle’s
medium (Invitrogen) supplemented with 10% (v/v)
foetal calf serum, 100 U/ml penicillin and 100 mg/ml
streptomycin at 378C in a humidified atmosphere of
95% air/5% CO2. The cells were always passaged
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Figure 1. Structures of TEMPOL and MitoTEMPOL.
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passage number 10.
Assays
The concentration of ferrous iron was measured by
the Ferrozine assay [35]. A sample of the reaction
mixture (100 ml) was added to 900 mlo f1m M
Ferrozine in water, rapidly mixed and left to react
for 10 min. The absorbance of the complex was
measured at 562 nm and quanitified using an
extinction coefficient at 562 nm of 27 900 M
 1cm
 1
[36]. All experiments studying the oxidation of
ferrous iron by nitroxides were performed under an
inert atmosphere (Ar) to prevent oxidation of the
ferrous-EDTA complex by oxygen.
Superoxide dismutation was measured by the
cytochrome c-superoxide assay. Superoxide was pro-
duced by the reaction of xanthine oxidase (20 mU/
ml) with acetaldehyde (10 mM)i n5 0m M potassium
phosphate buffer (pH 8) supplemented with 500 mg/
ml ferricytochrome c (from bovine heart, Sigma) at
308C. The reduction of cytochrome c was measured
at 550 nm using a Shimadzu UV-2501PC spectro-
photometer. The effect of various compounds on
superoxide dismutation was expressed as a percen-
tage of the slope of cytochrome c reduction after the
addition, relative to the slope before the addition. We
tested whether MitoTEMPOL might affect cyto-
chrome c reduction artifactually by inhibiting the
activity of xanthine oxidase by using a fluorometric
xanthine oxidase assay in which the non-fluorescent
substrate pterine is converted by xanthine oxidase to
isoxanthopterine, which fluoresces at lEx 345 nm,
lEm 390 nm [37]. To a solution of pterine (20 mM)
in 50 mM potassium phosphate buffer (pH 8) was
added 20 mU/ml xanthine oxidase9100 mM Mito-
TEMPOL and, when the fluorescence increase was
measured, no difference in the activity of xanthine
oxidase with or without MitoTEMPOL was found
(data not shown).
Oxidation of SUVs by peroxyl radicals derived
from the decomposition of 2,2?-azobis(2-amidinopro-
pane) (AAPH) was measured using C11-BOD-
IPY(581/591) (Molecular Probes) [38]. SUVs (1
mg/ml) suspended in 50 mM Tris-Cl buffer (pH 7)
(see above) were transferred to a quartz 3 ml cuvette
and placed in a Shimadzu RF-5301PC fluorimeter
thermostatted at 388C with stirring. The vesicles were
pre-incubated for 10 min with 200 nM C11-BODIPY
to allow their incorporation into the lipid phase. After
the addition of AAPH (25 mM) the decay of red
fluorescence was followed at lEx 540 nm, lEm 
590 nm.
Lipid peroxidation by hydrogen peroxide in bovine
heart mitochondrial membranes (BHM) was mea-
sured by the thiobarbituric acid-reactive species
(TBARS) assay [39]. BHM (1 mg protein) were
suspended in 800 ml5 0m M potassium phosphate
buffer (pH 8) supplemented with 25 mM glucose, 1
U/ml glucose oxidase (GO, from Aspergillus niger)9
compounds to be tested. The samples from these
incubations were then mixed with 0.1% di-tert-
butylhydroxytoluene (2% (w/v) solution in DMSO),
200 ml of 1% (w/v) thiobarbituric acid and 200 mlo f
35% (v/v) HClO4, heated at 1008C for 15 min,
diluted with 2 ml of water and extracted once into 2
ml of n-butanol. Quintuplicate 200 ml aliquots of the
butanol phase were transferred into a 96-well plate
and TBARS were determined fluorometrically (lEx 
515 nm, lEm 553 nm) in a Molecular Devices
Spectra Max Gemini XS fluorometric plate reader.
A standard curve of malondialdehyde (MDA) was
prepared using serial dilutions of a 10 mM solution of
1,1,3,3-tetraethoxypropane hydrolysed overnight in
1% (v/v) sulphuric acid at 48C.
EPR measurements
All spectra were acquired at room temperature
(  23 258C) in a Bruker EMX spectrometer using
the standard high-sensitivity resonator cavity ER
4102ST and a 300 mL quartz flat cell. Spectra were
batch-analysed using a Perl script written by JT for
this purpose. Quantitative results were expressed as
the height of the low-field peak of the nitroxide
spectrum [40].
Quantitative PCR (QPCR) assay
Damage to mitochondrial DNA (mtDNA) was mea-
sured by the quantitative PCR method [41]. C2C12
cells were seeded onto 6-well plates at 200 000 cells/
well in culture medium and incubated overnight to
adhere. Various concentrations of nitroxides or other
compounds were then added and the cells were
incubated for 1 h. Thereafter 25 mM menadione was
added and cells were incubated for a further 1 h. The
medium was then removed from the wells and cells
were washed with 1 ml ice-cold phosphate-buffered
saline (PBS) and harvested by scraping into 0.5 ml
ice-cold PBS. Cells were then pelleted by centrifuga-
tion at 16 000 g for 3 min in a benchtop centrifuge.
The pellet was re-suspended in 200 ml cold PBS.
Total cellular DNA was isolated using a DNeasy
Blood & Tissue Kit from Qiagen according to the
manufacturer’s instructions with minor modifica-
tions. Cells were lysed by the addition of 200 ml
proprietary lysis buffer. A solution of proteinase K
was added (20 ml) and the lysate was incubated for 10
min at 708C. Ethanol (210 ml) was then added and
the lysate was transferred into DNA isolation col-
umns, which were then centrifuged at 16 000 g for
1 min and then sequentially washed with the two
proprietary washing buffers. DNA was then eluted
with 3 40 ml of elution buffer pre-heated to 708C.
Isolated DNA was then quantified fluorometrically
6 J. Trnka et al.using the PicoGreen assay (Molecular Probes) and
stored in TE buffer at 208C. The DNA was then
diluted to a final concentration of 3 ng/ml, which was
used as a template for PCR. The total volume for
each PCR reaction was 50 ml, consisting of 15 ng
DNA template, 35 ml PCR mastermix and 1 U rTth
DNA polymerase XL (Applied Biosystems). The
mastermix consisted of 5 mg BSA, 200 mM dNTP,
20 pmol forward primer, 20 pmol reverse primer and
1.0 mM magnesium acetate and was made up to 35 ml
with nuclease-free water. The magnesium concentra-
tion was decreased to 0.9 mM for the short mito-
chondrial target. The primers for murine mtDNA
were synthesized by Sigma-Genosys. Their sequences
are:
. Short target: 5?-GCC AGC CTG ACC CAT AGC
CATAAT-3? 5?-GCC GGC TGC GTATTC TAC
GTT A-3?
. Long target: 5?-GCC AGC CTG ACC CAT AGC
CAT AAT-3? 5?-GAG AGA TTT TAT GGG TGT
AAT GCG G-3?
The PCR was begun with a manual hot-start: the
mastermix and template were heated to 758C, after
which the polymerase was added. The parameters for
the short mitochondrial target were 23 cycles of 30 s
at 948C, 45 s at 648C, 45 s at 728C, followed by 10
min at 728C. The parameters for the long mitochon-
drial target were 1 min at 948C, then 16 cycles of 15 s
at 948C, 12 min at 648C, followed by a final extension
step of 10 min at 728C. The amplified DNA was then
quantified using the PicoGreen assay (Molecular
Probes) and the results expressed as amplification
relative to the control (cells with no additions).
Statistics
All data were analysed using unpaired two-tailed
Student’s t-test in Microsoft Excel for Mac.
Results
Superoxide dismutase activity of MitoTEMPOL and
MitoTEMPOL-H
Since piperidine nitroxides are known to be super-
oxide dismutase (SOD)-mimetics we examined
whether superoxide dismutation by TEMPOL was
altered by adding an alkylTPP chain. Figure 2 shows
the superoxide-quenching activity of MitoTEMPOL,
the untargeted parent compound TEMPOL and
CuZn-SOD in the cytochrome c superoxide assay.
The rate of cytochrome c reduction by superoxide is
significantly lowered by all three compounds while
propylTPP, used as a control for the effect of TPP,
has a negligible effect. The superoxide-quenching
abilities of MitoTEMPOL and TEMPOL were
comparable, suggesting that the addition of TPP to
TEMPOL has little effect on its reactivity with
superoxide. The reaction of MitoTEMPOL with
superoxide was catalytic as, from EPR measurements,
the concentration of MitoTEMPOL was unchanged
over a 30 min reaction period (data not shown). In
contrast to MitoTEMPOL, the hydroxylamine, Mi-
toTEMPOL-H, had no measurable SOD-mimetic
activity (data not shown).
Reaction of MitoTEMPOL and MitoTEMPOL-H with
ferrous/ferric ions
Cyclic nitroxides may also act as antioxidants by
oxidizing cuprous and ferrous ions, thereby prevent-
ing oxidative damage resulting from the Fenton
reaction. Figure 3A shows that MitoTEMPOL ra-
pidly oxidizes the ferrous-EDTA complex, while the
control compound, propylTPP, has no effect. To
assess the reverse reaction of MitoTEMPOL-H with
ferric-EDTA we measured the nitroxide concentra-
tion by EPR (Figure 3B). This experiment shows that
there is some oxidation of MitoTEMPOL-H by ferric
ions to form MitoTEMPOL and presumably ferrous
iron. Thus, any antioxidant effects of MitoTEM-
POL-H are not a result of modifying the Fenton
reaction.
Prevention of lipid peroxidation by MitoTEMPOL and
MitoTEMPOL-H
In addition to catalysing superoxide dismutation and
oxidizing ferrous and cuprous ions, piperidine nitr-
oxides can react directly with a variety of free radicals
and detoxify them. Therefore we tested the ability of
MitoTEMPOL to prevent lipid peroxidation. To do
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Figure 2. Superoxide dismutase activity of MitoTEMPOL.
Superoxide was produced by mixing 20 mU xanthine oxidase with
10 mM acetaldehyde in 50 mM potassium phosphate buffer (pH 8)
supplemented with 500 mg/ml ferricytochrome c at 378C. The rate
of cytochrome c reduction was followed at 550 nm for 60 s after
which the appropriate amount of SOD, MitoTEMPOL, TEMPOL
or propylTPP was added and the rate was followed for another 60
s. The slope of the cytochrome c reduction progress curve was
measured after each addition and is expressed as a percentage of
the slope before the addition. Results are means9SD of three
measurements. ** pB0.01; § pB0.05 with respect to the same
concentration of MitoTEMPOL.
Antioxidant properties of MitoTEMPOL 7this we used small unilamellar phospholipid vesicles
(SUVs) incorporating the fluorescent peroxidation
probe C11-BODIPY, and initiated lipid peroxidation
by addition of the free radical generator 2,2?-azo-
bis(2-amidinopropane) (AAPH) (Figure 4). The
fluorescence of C11-BODIPY declined over time
after addition of AAPH consistent with lipid perox-
idation (Figure 4A). While MitoTEMPOL slowed
this peroxidation, the hydroxylamine form, Mito-
TEMPOL-H, was far more protective. This is
particularly evident in the data in the bar chart
(Figure 4B) obtained from repeated experiments.
Next, we compared the protective effect against lipid
peroxidation of MitoTEMPOL-H with that of an-
other mitochondria-targeted antioxidant, the ubiqui-
nol (MitoQH2) form of MitoQ (Figure 4C and D).
These data show that MitoTEMPOL-H is similar in
efficacy to MitoQH2, which is well established to be
effective at decreasing lipid peroxidation in a number
of systems and to prevent mitochondrial oxidative
damage in vivo [28,42].
To determine if MitoTEMPOL and MitoTEM-
POL-H decrease lipid peroxidation in more biologi-
cally relevant systems, we investigated bovine heart
mitochondrial membranes exposed to hydrogen per-
oxide and measured thiobarbituric acid-reactive spe-
cies (TBARS) as a marker of lipid peroxidation
(Figure 4E). Both TEMPOL and MitoTEMPOL
prevented lipid peroxidation, but MitoTEMPOL is
significantly more effective, probably due to its higher
affinity to phospholipids bilayers [18]. Consistent
with the findings from the C11-BODIPY assay,
MitoTEMPOL-H is also a more effective antioxidant
against lipid peroxidation than MitoTEMPOL in this
system. Finally, we assessed the ability of MitoTEM-
POL to prevent lipid peroxidation in intact, energized
mitochondria exposed to ferrous iron to induce lipid
peroxidation, measured by the TBARS assay (Figure
4F). MitoTEMPOL (1 mM) significantly reduced
lipid peroxidation, while the TPP control compound
was ineffective (Figure 4F). As MitoTEMPOL is very
rapidly and completely converted to MitoTEMPOL-
H within energized mitochondria [18], this protec-
tion is ascribed to MitoTEMPOL-H and demon-
strates that MitoTEMPOL-H is an effective
antioxidant within mitochondria.
Antioxidant mechanism of MitoTEMPOL-H
The most likely mechanism by which MitoTEM-
POL-H could act as an antioxidant is through the
chain-breaking donation of a hydrogen atom to a
lipid-derived or other radical [24], thereby producing
the nitroxide radical (MitoTEMPOL). To see if this
occurred we reacted MitoTEMPOL-H with radicals
generated by AAPH. Under these conditions the
concentration of the nitroxide MitoTEMPOL in-
creased over time significantly faster than by simple
auto-oxidation in the absence of AAPH (Figure 5).
Therefore MitoTEMPOL-H can react with radicals
to produce the nitroxide MitoTEMPOL, which in
vivo would be rapidly recycled to the hydroxylamine
by ubiquinol within mitochondria [18].
Mitochondrial protection by MitoTEMPOL in cells
We have established a plausible antioxidant model of
action of MitoTEMPOL within cells whereby it will
be taken up selectively into mitochondria and there
converted to MitoTEMPOL-H, selectively protecting
mitochondria from oxidative damage [18]. To see if
this was the case, we investigated whether MitoTEM-
POL protected against oxidative damage to mito-
chondrial DNA (mtDNA). Oxidative damage was
induced by using the redox cycler menadione, which
is known to generate superoxide within mitochondria
that can lead to lipid oxidation, as well as to a number
of other types of oxidative damage such as lipid
peroxidation, all of which can damage mtDNA
[43,44]. A quantitative PCR (QPCR) assay was
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Figure 3. Interactions of MitoTEMPOL and MitoTEMPOL-H
with iron. (A) MitoTEMPOL oxidizes ferrous iron. To a solution of
EDTA (100 mM) was added 100 mM freshly prepared FeCl2 and a
solution of a nitroxide or propylTPP as a control. The reaction
mixture was kept anaerobic under a stream of argon. Samples (100
ml) were taken at speciﬁed intervals, immediately mixed with 1 mM
Ferrozine (900 ml) and the concentration of the resulting complex
measured spectrophotometrically at 562 nm. Results are means9
SD of three experiments. (B) MitoTEMPOL-H reduces ferric ions.
MitoTEMPOL-H (6 mM) was mixed with 100 mM ferric EDTA in
anaerobic (N2-purged) 50 mM Tris-Cl buffer (pH 7). The
concentration of MitoTEMPOL was measured by EPR. The
nitroxide signal in the ‘no addition’ samples is due to background
oxidation of the hydroxylamine. Results are means9SD of three
experiments.
8 J. Trnka et al.utilized to measure oxidative damage to mtDNA by
comparing the relative amplification of a short and a
very long segment of mtDNA. Any decrease in
relative amplification of the long segment was due
to DNA damage and therefore an indication of
general oxidative damage to the mtDNA. A further
advantage of this procedure is that there is no need to
isolate mitochondria or to separate mtDNA from
nuclear DNA, thereby avoiding artefacts caused by
differential recovery of mitochondria or mtDNA
following damage.
The relative amplification of mtDNA decreased in
cells that were oxidatively stressed by menadione due
to mtDNA damage (Figure 6A). The presence of
MitoTEMPOL decreases this damage to mtDNA
(Figure 6A). The same concentration of the untar-
geted nitroxide TEMPOL is significantly less effec-
tive than MitoTEMPOL at preventing mtDNA
0
20
40
60
80
100
05 0 0 1000 1500 1800 
time (s) 
100 µM MitoTEMPOL-H
100 µM MitoTEMPOL
no additions 
0
20
40
60
80
100
0 5 10 15 20 30 
no additions  100 µM MitoTEMPOL 100 µM MitoTEMPOL-H  A B
0 
20 
40 
60 
80 
100 
0 500 1000 1500 1800 
time (s) 
50 µM MitoTEMPOL-H 
50 µM MitoQH2  
10 µM MitoTEMPOL-H 
10 µM MitoQH2 
0
20
40
60
80
100
0 51 01 52 0 3 0   0 5 10 15 20 30 
time (min)
f
l
u
o
r
e
s
c
e
n
c
e
 
(
%
t
0
)
 
f
l
u
o
r
e
s
c
e
n
c
e
 
(
%
t
0
)
 
* 
** 
10 µM 50  µM 
MitoTEMPOL-H  MitoQH2 
C  D
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
n
m
o
l
 
M
D
A
/
m
g
 
p
r
o
t
e
i
n
 
control  G/GO  + 10  µM 
MitoTEMPOL 
+ 10  µM 
TEMPOL 
+ 10  µM 
MitoTEMPOL-H 
** 
**  * *  
** 
E
0 
1 
2 
3 
4 
Fe +1µM 
MitoTEMPOL
Fe + 1µM
propylTPP
n
m
o
l
 
M
D
A
/
m
g
 
p
r
o
t
e
i
n
 
N.S. 
* *   F
time (min)
time (min)
0
20
40
60
80
100
f
l
u
o
r
e
s
c
e
n
c
e
 
(
%
t
0
)
 
f
l
u
o
r
e
s
c
e
n
c
e
 
(
%
t
0
)
 
control 10µM FeCl2
Figure 4. Antioxidant reactions of MitoTEMPOL. (A and B) MitoTEMPOL and MitoTEMPOL-H prevent lipid peroxidation in
phospholipid vesicles. Small univesicular phosphatidylcholine vesicles (SUVs) (1 mg/ml) were suspended in 50 mM Tris-Cl buffer (pH 7)
and pre-incubated for 10 min with 200 nM C11-BODIPYand either vehicle, 100 mM MitoTEMPOL or 100 mM MitoTEMPOL-H at 388C.
To this mixture AAPH (25 mM) was added and the changes in ﬂuorescence were followed at lEx 540 nm, lEm 590 nm. (A) Typical
traces. (B) Fluorescence at various times as a percentage of time zero: data are means9SD of three experiments. (C and D) Comparison of
the antioxidant activities of MitoTEMPOL-H and reduced MitoQ (MitoQH2). Experimental conditions are as described for panels A and
B: * pB0.05; ** pB0.01 vs time zero. (E) MitoTEMPOL, MitoTEMPOL-H and TEMPOL prevent TBARS formation in mitochondrial
membranes stressed with H2O2. Bovine heart mitochondrial membranes (1 mg protein) were suspended in 800 mlo f5 0m M potassium
phosphate buffer (pH 8) supplemented with 25 mM glucose and were incubated with 1 U/ml glucose oxidase for 30 min at 378C. TBARS
were measured relative to a malondialdehyde (MDA) standard curve as described in Materials and methods. Data are means9SD of three
experiments ** pB0.01. (F) MitoTEMPOL prevents TBARS formation in rat liver mitochondria stressed with ferrous iron. Mitochondria
(2 mg protein) were suspended in 800 ml Tris-buffered KCl medium (100 mM KCl, 10 mM Tris-Cl, pH 7.6) supplemented with 10 mM
glutamate/malate and incubated with 10 mM FeCl291 mM MitoTEMPOL or propylTPP for 30 min at 378C. TBARS were measured as
described in Materials and methods. Results are means9SD of three experiments. ** pB0.01, NS, not signiﬁcant.
Antioxidant properties of MitoTEMPOL 9damage (Figure 6B). The TPP compound pro-
pylTPP, which lacks the nitroxide moiety, exhibits
no protective effect, indicating that the protection is
not due to the non-specific uptake of TPP com-
pounds into mitochondria (Figure 6C). These results
indicate that MitoTEMPOL can selectively protect
mitochondria in cells from oxidative damage and this
effect requires both the nitroxide moiety and the
targeting into mitochondria.
Discussion
Here we have shown that the mitochondria-targeted
antioxidant MitoTEMPOL has similar in vitro anti-
oxidant efficacy to its precursor TEMPOL, indicating
that conjugation to TPP does not interfere with the
antioxidant activity of TEMPOL. Previously we have
shown that MitoTEMPOL is very rapidly converted
to the hydroxylamine MitoTEMPOL-H by ubiquinol
in mitochondria and cells [18]. Therefore, it is
unlikely that there will be any MitoTEMPOL present
in a biological situation and that the dominant
compound will be MitoTEMPOL-H. The antioxi-
dant efficacy of MitoTEMPOL-H was quite different
from that of MitoTEMPOL, as it had no SOD-
mimetic activity nor could it oxidize ferrous iron.
However, MitoTEMPOL-H was a very effective
chain-breaking antioxidant, preventing lipid peroxi-
dation. This reaction was shown to occur by the
transfer of a hydrogen atom from MitoTEMPOL-H
to quench a radical. While this reaction generates
MitoTEMPOL, in mitochondria this nitroxide would
be rapidly converted back to MitoTEMPOL-H.
Therefore, a plausible mode for the antioxidant
activity of MitoTEMPOL in mitochondria and cells
is that it is rapidly converted to MitoTEMPOL-H
within mitochondria and acts as a chain breaking
antioxidant against free radicals by donating a hydro-
gen atom. In doing so, it is converted to the nitroxide
MitoTEMPOL, which is then rapidly recycled back
to MitoTEMPOL-H by mitochondrial ubiquinol.
Thus, MitoTEMPOL may be an effective antioxidant
as it is capable of being rapidly recycled within
mitochondria by the respiratory chain, in a similar
manner to MitoQ [34,42].
Consequently, even though MitoTEMPOL is ra-
pidly converted to MitoTEMPOL-H this should still
lead to effective antioxidant protection against mito-
chondrial damage. This is because MitoTEMPOL-H
is a good antioxidant, it is accumulated by mitochon-
dria, will be rapidly recycled by ubiquinol in mito-
chondria and has a strong affinity for the surface of
phospholipid bilayers, where most oxidative damage
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duces MitoTEMPOL. MitoTEMPOL-H (1 mM) was incubated9
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taken at given time points and the intensity of the nitroxide signal
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Figure 6. MitoTEMPOL protects mitochondrial DNA from
damage by menadione. (A C) C2C12 cells were seeded in 6-well
plates at 300 000 cells/well and left to attach overnight in medium.
They were then pre-incubated for 1 h with medium containing 50
mM MitoTEMPOL or propylTPP after which 25 mM menadione
was added and cells were incubated for a further 1 h at 378C. Cells
were then harvested by scraping, the DNA was isolated and
ampliﬁed by QPCR and the product quantiﬁed using PicoGreen.
Results are means9SEM of three experiments. * pB0.05; ** pB
0.01, NS, non-signiﬁcant.
10 J. Trnka et al.occurs within mitochondria. This was confirmed
within cells, where MitoTEMPOL was shown to be
protective against mitochondrial oxidative damage
to mtDNA caused by the redox cycler mena-
dione. Therefore, targeting a piperidine nitroxide to
mitochondria is an effective antioxidant strategy, even
if the nitroxide is rapidly converted to its hydroxyla-
mine, and our results suggest that the efficacy of
mitochondria-targeted TEMPOL should be assessed
in a range of other systems, where mitochondria-
targeted antioxidants such as MitoQ have been shown
to be effective. In addition, these findings suggest that
some of the antioxidant efficacy of TEMPOL in vivo
may be due to its hydroxyalmine.
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